The global periodontal therapeutic market is expected to grow significantly over the forecast period. It is estimated that the global periodontal therapeutic market is expected to register a CAGR of ~ 9.2 % during the forecast period from 2018 to 2023.
Periodontal is a chronic inflammatory disease of the periodontium. It is the main cause of tooth loss and is considered one of the two biggest threats to oral health. Periodontal disease is prevalent in both developed and developing countries and affects about 20 to 50% of the global population. Hence periodontal therapies are used to treat periodontal disease. It can be treated by either surgical or non-surgical treatment. Various factors such as smoking, poor oral hygiene, hormonal changes in females, diabetes mellitus, stress are responsible for periodontal diseases. These factors are also driving for the growth of the periodontal therapeutic market. According to world health organization, gingival bleeding is highly prevalent among adult populations in all regions of the world; advanced disease with deep periodontal pockets (6 mm or more) affects 10 to 15% of adults worldwide.
Segmentation
The global periodontal therapeutic market has been segmented on basis of type, treatment, and end-users. On basis of type, the market is segmented into three types such as gingivitis, chronic periodontitis, aggressive periodontitis, and necrotizing periodontal disease. Based on treatment, the market is segmented into two segments such as systematic antibiotics and local antibiotics. Systematic antibiotics are further sub-segmented into doxycycline, minocycline, metronidazole, and others. Local antibiotics are further segmented into arestin, chlorhexidine, and others. On basis of end-user market is further is segmented into dental clinics and hospitals.
Key players
Key players in the global periodontal therapeutic market are Fibrocell Sciences, Inc, Tolmar Inc, Eli Lilly & Company, Align Technology Inc., Dentsply International, 3M-ESPE, Ultradent Products Inc, Nobel Biocare Holdings AG, Glidewell Laboratories, Inc, Orapharma, Kaken Pharmaceutical, Valeant Pharmaceuticals Int. Inc, Den-Mat Holdings, Mallinckrodt Pharmaceuticals, Purdue Pharma L.P., Teva Pharmaceutical Industries Limited.
Global Periodontal Therapeutic Market, by Types
- Gingivitis
- Chronic periodontitis
- Aggressive periodontitis
- Necrotizing periodontal disease
Global Periodontal Therapeutic Market, by Treatment
- Systematic Antibiotics
- Doxycycline
- Minocycline
- Metronidazole
- Others
- Local Antibiotics
- Arestin
- Chlorhexidine
- Others
Global Periodontal Therapeutic Market, by End-Users
Request Customization
Get a Sample
Get a Sample
Request Customization